CD8A and nonpapillary renal cell carcinoma: Recently, APLN receptor (APLNR) was considered to be an essential gene for tumor immunotherapy, which can modulate the function of CD8+T cells, but the immunological effects of the APLN/APLNR axis in ccRCC remain unknown (Tolkach et al., 2019).